Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder

Depression and Anxiety
Jeffrey R Strawn, Thomas D Geracioti


The catecholamine norepinephrine is a critical effector of the mammalian stress response and has been implicated in the pathophysiology of posttraumatic stress disorder (PTSD)-a syndrome intrinsically related to the experience of extraordinary stress. Symptom-linked hypernoradrenergic derangements have been observed in PTSD and several studies have examined the potential therapeutic effects of agents that dampen the centrally hyperactive noradrenergic state. These agents include compounds that decrease norepinephrine release (e.g. centrally acting alpha(2) agonists such as clonidine) and those which block post-synaptic norepinephrine receptors (e.g. centrally acting alpha(1) or beta receptor antagonists such as prazosin or propranolol). In this article, we review studies of central noreadrenergic hyperactivity under both basal and challenge conditions and explore the evidence for these derangements as potential psychopharmacologic targets in patients with PTSD. Given the significant involvement of CNS norepinephrine hyperactivity in PTSD, and its link to intrusive and hyperarousal symptoms, it is not surprising that interventions directed at this system have therapeutic potential in PTSD. The utility of these anti-adrenergics i...Continue Reading


Aug 3, 2010·Psychopharmacology·Nicholas W Gilpin, George F Koob
Jan 13, 2011·Journal of Clinical Psychology in Medical Settings·Judith AlderIrene Hoesli
Jul 18, 2012·Molecular Psychiatry·R Sah, Thomas D Geracioti
Apr 9, 2013·Nature Neuroscience·Wataru InoueJaideep S Bains
Jun 21, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Shlomi CohenHagit Cohen
Feb 5, 2009·Nature Reviews. Neuroscience·Susan J Sara
Nov 28, 2013·Proceedings of the National Academy of Sciences of the United States of America·Robert M SearsJoseph E Ledoux
Nov 3, 2009·The Clinical Neuropsychologist·Thomas W McAllister
Nov 3, 2009·Journal of Child and Adolescent Psychopharmacology·Jeffrey R StrawnThomas D Geracioti
May 21, 2013·Journal of Child and Adolescent Psychopharmacology·Daniel F ConnorAlok Banga
Jan 15, 2010·Journal of Pediatric Psychology·Laura StoppelbeinPaula J Fite
Oct 30, 2013·Disease Markers·Ulrike SchmidtCarsten T Wotjak
Dec 17, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nikolai C DembrowDaniel Johnston
Apr 1, 2007·Neuropsychiatric Disease and Treatment·Jeffrey R Strawn, Thomas D Geracioti
Feb 7, 2014·Annual Review of Clinical Psychology·Andrea N Goldstein, Matthew P Walker
Jul 19, 2014·Journal of Psychiatric Practice·Ben Green
Aug 20, 2014·Translational Psychiatry·M SquillaceA Gozzi
Oct 11, 2014·Nature Reviews. Neuroscience·Takeshi Sakurai
Oct 10, 2014·Journal of Child and Adolescent Psychopharmacology·Presenters Revital RacinDiscussant Barbara J Coffey
Jan 26, 2016·Neurobiology of Learning and Memory·Thomas F GiustinoStephen Maren
May 28, 2015·Expert Opinion on Emerging Drugs·James W MurroughDennis S Charney
Feb 14, 2016·Neuroscience and Biobehavioral Reviews·Ivone Castro-ValeDavide Carvalho
Mar 25, 2014·Child and Adolescent Psychiatric Clinics of North America·Brooks R Keeshin, Jeffrey R Strawn
Jan 1, 2014·Journal of the American Academy of Dermatology·Sara R HoganDavid Eilers
Apr 10, 2013·Neuroscience and Biobehavioral Reviews·Phillip R Zoladz, David M Diamond
Oct 6, 2012·La Revue de médecine interne·Y Auxéméry
Mar 1, 2011·Sleep Medicine Clinics·Els van der Helm, Matthew P Walker
Sep 14, 2010·Clinics in Laboratory Medicine·Elizabeth I MartinCharles B Nemeroff
Jul 14, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yi-lang TangJoseph F Cubells
Sep 1, 2009·The Psychiatric Clinics of North America·Elizabeth I MartinCharles B Nemeroff
May 9, 2009·Current Opinion in Genetics & Development·Katharina WulffRussell G Foster
Sep 11, 2007·Neuroscience and Biobehavioral Reviews·Willie Langeland, Miranda Olff


May 15, 1992·Biological Psychiatry·M E McFallM M Murburg
May 1, 1992·The Journal of Nervous and Mental Disease·R YehudaJ W Mason
Jun 1, 1991·The Journal of Nervous and Mental Disease·E B BlanchardG C McCoy
Jan 1, 1990·Annals of the New York Academy of Sciences·S V BhaveA R Wakade
Sep 1, 1989·The Journal of Nervous and Mental Disease·J D Kinzie, P Leung
Sep 1, 1988·The Journal of Clinical Investigation·A E CalogeroP W Gold
Nov 1, 1988·American Journal of Diseases of Children·R FamularoT Fenton
May 1, 1988·Clinical Pharmacokinetics·D T LowenthalT R MacGregor
Nov 1, 1987·Journal of Neurochemistry·D S GoldsteinH R Keiser
Nov 1, 1987·Archives of General Psychiatry·R K PitmanJ M Claiborn
Jan 1, 1982·The Psychiatric Quarterly·E B BlanchardR J Gerardi
Aug 1, 1995·Biological Psychiatry·T A MellmanB Nolan
Mar 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·M D De BellisF W Putnam
Apr 1, 1993·Archives of General Psychiatry·S M SouthwickDennis S Charney
May 1, 1996·Synapse·J D BremnerDennis S Charney
Dec 15, 1995·Biological Psychiatry·M M MurburgR C Veith
Aug 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·J P Horrigan
Sep 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·R J Harmon, P D Riggs
May 1, 1997·The American Journal of Psychiatry·J D BremnerDennis S Charney
Aug 1, 1997·Archives of General Psychiatry·S M SouthwickDennis S Charney
Nov 28, 1997·Psychoneuroendocrinology·D G BakerThomas D Geracioti
Apr 15, 1999·Biological Psychiatry·I LiberzonL M Fig
Jun 24, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·I LiberzonE A Young
Nov 24, 1999·Biological Psychiatry·E J NestlerG K Aghajanian
Nov 24, 1999·Biological Psychiatry·S M SouthwickDennis S Charney
Nov 24, 1999·Biological Psychiatry·Kerry J Ressler, Charles B Nemeroff

Related Concepts

Biological Adaptation to Stress
Neurologic Manifestations
Catecholamine [EPC]
Hyperactive Behavior
Post-Traumatic Stress Disorder
Norepinephrine, (+, -)-Isomer
Adrenergic alpha-Agonists
Adrenergic alpha-Antagonists
Norepinephrine Measurement

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.